Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress. | Brain Pathol | 2021 | 33786950 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition. | Nat Commun | 2021 | 33767183 | PubTator, text mining | PubMed |
| A protective role for autophagy in vitiligo. | Cell Death Dis | 2021 | 33767135 | PubTator, text mining | PubMed |
| Adipose tissue parasite sequestration drives leptin production in mice and correlates with human cerebral malaria. | Sci Adv | 2021 | 33762334 | PubTator, text mining | PubMed |
| Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results. | Clin Cancer Res | 2021 | 33753457 | PubTator, text mining | PubMed |
| Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers. | Nat Commun | 2021 | 33741979 | PubTator, text mining | PubMed |
| Phosphatidic acid-mediated binding and mammalian cell internalization of the Vibrio cholerae cytotoxin MakA. | PLoS Pathog | 2021 | 33735319 | PubTator, text mining | PubMed |
| A positive feedback loop between mTORC1 and cathelicidin promotes skin inflammation in rosacea. | EMBO Mol Med | 2021 | 33734592 | PubTator, text mining | PubMed |
| Pharmacological inhibition of mTORC1 activity protects against inflammation-induced apoptosis of nucleus pulposus cells. | Braz J Med Biol Res | 2021 | 33729389 | PubTator, text mining | PubMed |
| Fasting-induced FOXO4 blunts human CD4+ T helper cell responsiveness. | Nat Metab | 2021 | 33723462 | PubTator, text mining | PubMed |
Transcriptomic Profiling of In Vitro Tumor-Stromal Cell Paracrine Crosstalk Identifies Involvement of the Integrin Signaling Pathway in the Pathogenesis of Mesenteric Fibrosis in Human Small Intestinal Neuroendocrine Neoplasms. | Front Oncol | 2021 | 33718208 | PubTator, text mining | PubMed |
| Copanlisib for the Treatment of Malignant Lymphoma: Clinical Experience and Future Perspectives. | Target Oncol | 2021 | 33687623 | PubTator, text mining | PubMed |
| Genomic Alterations in PIK3CA-Mutated Breast Cancer Result in mTORC1 Activation and Limit the Sensitivity to PI3Kα Inhibitors. | Cancer Res | 2021 | 33685991 | PubTator, text mining | PubMed |
| The glutamine antagonist prodrug JHU-083 slows malignant glioma growth and disrupts mTOR signaling. | Neurooncol Adv | 2021 | 33681764 | PubTator, text mining | PubMed |
| Knockdown of AKT3 Activates HER2 and DDR Kinases in Bone-Seeking Breast Cancer Cells, Promotes Metastasis In Vivo and Attenuates the TGFβ/CTGF Axis. | Cells | 2021 | 33670586 | PubTator, text mining | PubMed |
| CrossTORC and WNTegration in Disease: Focus on Lymphangioleiomyomatosis. | Int J Mol Sci | 2021 | 33668092 | PubTator, text mining | PubMed |
| First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models. | Breast Cancer Res | 2021 | 33663585 | PubTator, text mining | PubMed |
| mTORC1 activity is supported by spatial association with focal adhesions. | J Cell Biol | 2021 | 33635313 | PubTator, text mining | PubMed |
| Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in Melanoma. | Mol Cancer Ther | 2021 | 33632871 | PubTator, text mining | PubMed |
| Fructose reprogrammes glutamine-dependent oxidative metabolism to support LPS-induced inflammation. | Nat Commun | 2021 | 33619282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=36